The Role of Stem Cells as Therapeutics for Ischaemic Stroke
Open Access
Abstract
Stroke remains one of the leading causes of death and disability worldwide. Current reperfusion treatments for ischaemic stroke are limited due to their narrow therapeutic window in rescuing ischaemic penumbra. Stem cell therapy offers a promising alternative. As a regenerative medicine, stem cells offer a wider range of treatment strategies, including long-term intervention for chronic patients, through the reparation and replacement of injured cells via mechanisms of differentiation and proliferation. The purpose of this review is to evaluate the therapeutic role of stem cells for ischaemic stroke. This paper discusses the pathology during acute, subacute, and chronic phases of cerebral ischaemic injury, highlights the mechanisms involved in mesenchymal, endothelial, haematopoietic, and neural stem cell-mediated cerebrovascular regeneration, and evaluates the pre-clinical and clinical data concerning the safety and efficacy of stem cell-based treatments. The treatment of stroke patients with different types of stem cells appears to be safe and efficacious even at relatively higher concentrations irrespective of the route and timing of administration. The priming or pre-conditioning of cells prior to administration appears to help augment their therapeutic impact. However, larger patient cohorts and later-phase trials are required to consolidate these findings.Keywords
All Related Versions
This publication has 184 references indexed in Scilit:
- GATA-2 mediated regulation of normal hematopoietic stem/progenitor cell function, myelodysplasia and myeloid leukemiaThe International Journal of Biochemistry & Cell Biology, 2012
- Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in strokeBrain, 2011
- Hypoxia. 2. Hypoxia regulates cellular metabolismAmerican Journal of Physiology-Cell Physiology, 2011
- Expansion of the Time Window for Treatment of Acute Ischemic Stroke With Intravenous Tissue Plasminogen ActivatorStroke, 2009
- Pulmonary Passage is a Major Obstacle for Intravenous Stem Cell Delivery: The Pulmonary First-Pass EffectStem Cells and Development, 2009
- Hematopoiesis: An Evolving Paradigm for Stem Cell BiologyCell, 2008
- Leucocyte common antigen (CD45) and CD5 positivity in an “undifferentiated” carcinoma: a potential diagnostic pitfallJournal of Clinical Pathology, 2007
- Apoptosis: A Review of Programmed Cell DeathToxicologic Pathology, 2007
- Interleukin-6 Stimulates Circulating Blood-Derived Endothelial Progenitor Cell Angiogenesis in vitroJournal of Cerebral Blood Flow & Metabolism, 2007
- Benefits, risks and ethical considerations in translation of stem cell research to clinical applications in Parkinson’s diseaseJournal of Medical Ethics, 2007